Chile approved AstraZeneca-Oxford vaccine, 4 million doses to buy

Chile’s health regulator approved the AstraZeneca-Oxford COVID-19 vaccine for emergency use among its population by a unanimous vote of its advisory board. Chile originally had a pre-deal to purchase 14.4 million doses of the AstraZeneca vaccine but last week President Piñera said the country had eventually signed to buy 4 million doses. Chile’s health ministry declined to give further details on why Chile did not buy the original quantity agreed.